Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Da Som JeonCheol-Kyu ParkSeung Joon KimChan Kwon ParkYoon Soo ChangChi Young JungSung-Yong LeeShin-Yup LeeJeong-Seon RyuJeong Eun LeeKye Young LeeTae Won JangSeung Hun JangSeong Hoon YoonSang Hoon LeeChang-Min ChoiHyeong Ryul KimYeon Joo KimPublished in: Thoracic cancer (2024)
ORR, PFS, OS, and adverse event profiles were comparable to previous clinical trials. Our findings could aid in the efficient management of ALK-positive lung cancer patients.